跳至主要内容
临床试验/EUCTR2012-000938-19-IT
EUCTR2012-000938-19-IT进行中(未招募)不适用

Safety and Efficacy of tablets containing extract of Hibiscus Sabdariffa (HS) and Propoli versus placebo in the treatment of the cystitis with Ciproxin

OVINTETHICAL PHARMA SAG0 个研究点开始时间: 2012年8月2日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients > o =18 years ; • Caucasian origin; • Normal physical examination, vital signs and laboratory evaluations; • Diagnosis of cystitis; • Infection of the urinary tract confirmed by urine culture • Sensitivity demonstrated to Ciprofloxacina • Antibiotic treatment based on Ciproxin for 5 days after the diagnosis of cystitis
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 80
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 20

排除标准

  • Patients < 18 years • No infection of the urinary tract confirmed by urine culture • No Sensitivity demonstrated to Ciprofloxacina • Impossibility to follow the antibiotic treatment with Ciproxin

研究者

发起方
OVINTETHICAL PHARMA SAG

相似试验